Sequella, Inc.
Industry
- Pharmaceuticals
Latest on Sequella, Inc.
In 2015, the number of tuberculosis (TB) attributed deaths totalled 1.5 million, outnumbering the 1.2 million deaths due to HIV. While this represents a 47% fall in mortality from TB since 1990, the W
World TB Day, which takes place each year on 24 March, is the event at which bodies like the World Health Organization and the Stop TB Partnership report on progress with efforts to fight TB and exhor
Sequella Inc. CEO Carol Nacy sees the company’s recent in-licensing deal with Pfizer as a turning point in the long road to developing anti-infectives to treat multidrug-resistant tuberculosis, and
IN VITRO DIAGNOSTICS Mergers & Acquisitions Metamark Genetics Inc. Endo Health Solutions Inc. HealthTronics Inc. HealthTronics Laboratory Solutions Endo International PLC (branded and generic drug